Skip to content

1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (AGPAT3)

Homo sapiens — UniProt Q9NRZ7

Gene: AGPAT3Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (AGPAT3) is a protein from Homo sapiens identified by UniProt accession Q9NRZ7, 376 residues long. MolForge cross-references it against 0 known binders and 224 disease associations.

  • UniProt accession: Q9NRZ7; gene symbol AGPAT3.
  • Organism: Homo sapiens.
  • Length: 376 amino acids.
  • Top disease associations (Open Targets): Intellectual disability, phosphatidylcholine measurement and glucose metabolism decline measurement.
  • 3D structure: AlphaFold model available.

Target properties

Protein name1-acyl-sn-glycerol-3-phosphate acyltransferase gamma
UniProt accessionQ9NRZ7
GeneAGPAT3
OrganismHomo sapiens
Length376 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (224)

Diseases linked to this target (Open Targets).

  • Intellectual disability · score 0.38
  • phosphatidylcholine measurement · score 0.26
  • glucose metabolism decline measurement · score 0.20
  • Neurodevelopmental disorder · score 0.18
  • breast adenocarcinoma · score 0.18
  • cystatin B measurement · score 0.17
  • triacylglycerol 54:5 measurement · score 0.14
  • blood protein measurement · score 0.14
  • glomerular filtration rate · score 0.12
  • azoospermia · score 0.09

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9NRZ7-F1alphafoldPREDICTED94.63—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9NRZ7.

Amino-acid sequence (376 residues)

MGLLAFLKTQ FVLHLLVGFV FVVSGLVINF VQLCTLALWP VSKQLYRRLN CRLAYSLWSQ LVMLLEWWSC TECTLFTDQA TVERFGKEHA VIILNHNFEI DFLCGWTMCE RFGVLGSSKV LAKKELLYVP LIGWTWYFLE IVFCKRKWEE DRDTVVEGLR RLSDYPEYMW FLLYCEGTRF TETKHRVSME VAAAKGLPVL KYHLLPRTKG FTTAVKCLRG TVAAVYDVTL NFRGNKNPSL LGILYGKKYE ADMCVRRFPL EDIPLDEKEA AQWLHKLYQE KDALQEIYNQ KGMFPGEQFK PARRPWTLLN FLSWATILLS PLFSFVLGVF ASGSPLLILT FLGFVGAASF GVRRLIGVTE IEKGSSYGNQ EFKKKE

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with AGPAT3?

The strongest Open Targets associations for AGPAT3 are Intellectual disability, phosphatidylcholine measurement, glucose metabolism decline measurement, Neurodevelopmental disorder and breast adenocarcinoma.

How long is the AGPAT3 protein?

The Homo sapiens AGPAT3 protein (UniProt Q9NRZ7) is 376 amino acids long.

Browse: Targets: A · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore 1-acyl-sn-glycerol-3-phosphate acyltransferase gamma with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9NRZ7
GeneAGPAT3
OrganismHomo sapiens
Length376
Binders0
Diseases224
View on UniProt